ENDRA Life Sciences (NDRA) Invested Capital (2022 - 2023)
ENDRA Life Sciences (NDRA) posted quarterly Invested Capital of $28484.0 for Q4 2023, little changed year-over-year from $28484.0 in Q4 2022, and little changed quarter-over-quarter from $28484.0 in Q3 2023.
ENDRA Life Sciences (NDRA) Invested Capital (2022 - 2023) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Invested Capital for 2 consecutive years, with $28484.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Invested Capital changed 0.0% year-over-year to $28484.0; the TTM figure through Sep 2024 stood at $28484.0 (down 66.67% YoY), while the FY2023 annual figure was $28484.0, changed 0.0% from the prior year.
- Invested Capital steadied at $28484.0 in Q4 2023 per NDRA's latest filing, from $28484.0 in the prior quarter.
- Across five years, Invested Capital topped out at $28484.0 in Q4 2022 and bottomed at $28484.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 3.37 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 1.41 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 519.00 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 304.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.29 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 22.35 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 67.29 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.00 Mn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28,484.00 |
| Sep 30, 2023 | 28,484.00 |
| Jun 30, 2023 | 28,484.00 |
| Dec 31, 2022 | 28,484.00 |